These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 27933339)

  • 1. Efficacy and safety of osteoporosis medications in a rat model of late-stage chronic kidney disease accompanied by secondary hyperparathyroidism and hyperphosphatemia.
    Ota M; Takahata M; Shimizu T; Kanehira Y; Kimura-Suda H; Kameda Y; Hamano H; Hiratsuka S; Sato D; Iwasaki N
    Osteoporos Int; 2017 Apr; 28(4):1481-1490. PubMed ID: 27933339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the Efficacy and Renal Safety of Bisphosphonate Between Low-Dose/High-Frequency and High-Dose/Low-Frequency Regimens in a Late-Stage Chronic Kidney Disease Rat Model.
    Fujita R; Ota M; Sato D; Nakazawa D; Kimura-Suda H; Nakamura F; Shimizu T; Kobayashi H; Iwasaki N; Takahata M
    Calcif Tissue Int; 2020 Oct; 107(4):389-402. PubMed ID: 32671419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
    Saag KG; Shane E; Boonen S; Marín F; Donley DW; Taylor KA; Dalsky GP; Marcus R
    N Engl J Med; 2007 Nov; 357(20):2028-39. PubMed ID: 18003959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alendronate retards the progression of lumbar intervertebral disc degeneration in ovariectomized rats.
    Luo Y; Zhang L; Wang WY; Hu QF; Song HP; Su YL; Zhang YZ
    Bone; 2013 Aug; 55(2):439-48. PubMed ID: 23500174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo effects of two novel ALN-EP4a conjugate drugs on bone in the ovariectomized rat model for reversing postmenopausal bone loss.
    Hu S; Liu CC; Chen G; Willett T; Young RN; Grynpas MD
    Osteoporos Int; 2016 Feb; 27(2):797-808. PubMed ID: 26272313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of bisphosphonates and treadmill exercise on bone and kidney in adenine-induced chronic kidney disease rats.
    Harata S; Kasukawa Y; Nozaka K; Tsuchie H; Shoji R; Igarashi S; Kasama F; Oya K; Okamoto K; Miyakoshi N
    J Bone Miner Metab; 2023 Nov; 41(6):785-796. PubMed ID: 37897671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Osteoporosis treatment for patients with chronic kidney disease].
    Konishi Y
    Nihon Rinsho; 2015 Oct; 73(10):1723-7. PubMed ID: 26529937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoporosis, bone mineral density and CKD-MBD: treatment considerations.
    Bover J; Bailone L; López-Báez V; Benito S; Ciceri P; Galassi A; Cozzolino M
    J Nephrol; 2017 Oct; 30(5):677-687. PubMed ID: 28432640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with eldecalcitol and alendronate has therapeutic advantages over monotherapy by improving bone strength.
    Sakai S; Endo K; Takeda S; Mihara M; Shiraishi A
    Bone; 2012 May; 50(5):1054-63. PubMed ID: 22366400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teriparatide Improves Trabecular Osteoporosis but Simultaneously Promotes Ankylosis of the Spine in the Twy Mouse Model for Diffuse Idiopathic Skeletal Hyperostosis.
    Hamano H; Takahata M; Ota M; Hiratsuka S; Shimizu T; Kameda Y; Iwasaki N
    Calcif Tissue Int; 2016 Feb; 98(2):140-8. PubMed ID: 26463185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphophonates in CKD patients with low bone mineral density.
    Liu WC; Yen JF; Lang CL; Yan MT; Lu KC
    ScientificWorldJournal; 2013; 2013():837573. PubMed ID: 24501586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The treatment of the patient presenting with chronic kidney disease (CKD) and fragility fractures].
    Giusti A; Fusaro M
    G Ital Nefrol; 2017 Dec; 34(Nov-Dec):. PubMed ID: 29207226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered material properties are responsible for bone fragility in rats with chronic kidney injury.
    Iwasaki Y; Kazama JJ; Yamato H; Matsugaki A; Nakano T; Fukagawa M
    Bone; 2015 Dec; 81():247-254. PubMed ID: 26187196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
    Meng Y; Zhang H; Li Y; Li Q; Zuo L
    Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand trap of the activin receptor type IIA inhibits osteoclast stimulation of bone remodeling in diabetic mice with chronic kidney disease.
    Sugatani T; Agapova OA; Fang Y; Berman AG; Wallace JM; Malluche HH; Faugere MC; Smith W; Sung V; Hruska KA
    Kidney Int; 2017 Jan; 91(1):86-95. PubMed ID: 27666759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of combination treatment with alendronate and raloxifene on skeletal properties in a beagle dog model.
    Allen MR; McNerny E; Aref M; Organ JM; Newman CL; McGowan B; Jang T; Burr DB; Brown DM; Hammond M; Territo PR; Lin C; Persohn S; Jiang L; Riley AA; McCarthy BP; Hutchins GD; Wallace JM
    PLoS One; 2017; 12(8):e0181750. PubMed ID: 28793321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiscale effects of the calcimimetic drug, etelcalcetide on bone health of rats with secondary hyperparathyroidism induced by chronic kidney disease.
    Sharma S; Kumar S; Tomar MS; Chauhan D; Kulkarni C; Rajput S; Sadhukhan S; Porwal K; Guha R; Shrivastava A; Gayen JR; Kumar N; Chattopadhyay N
    Bone; 2024 Aug; 185():117126. PubMed ID: 38777312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-emptive, early, and delayed alendronate treatment in a rat model of knee osteoarthritis: effect on subchondral trabecular bone microarchitecture and cartilage degradation of the tibia, bone/cartilage turnover, and joint discomfort.
    Mohan G; Perilli E; Parkinson IH; Humphries JM; Fazzalari NL; Kuliwaba JS
    Osteoarthritis Cartilage; 2013 Oct; 21(10):1595-604. PubMed ID: 23827368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rat model of SHPT with bone abnormalities in CKD induced by adenine and a high phosphorus diet.
    Ni LH; Tang RN; Lv LL; Wu M; Wang B; Wang FM; Ni HF; Song KY; Wang LT; Meng-Zuo ; Chen Q; Liu BC
    Biochem Biophys Res Commun; 2018 Apr; 498(3):654-659. PubMed ID: 29545182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Sequential Treatment with Bisphosphonates After Teriparatide in Ovariectomized Rats: A Direct Comparison Between Risedronate and Alendronate.
    Yano T; Yamada M; Inoue D
    Calcif Tissue Int; 2017 Jul; 101(1):102-110. PubMed ID: 28337514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.